EAERX
Price
$23.05
Change
-$0.19 (-0.82%)
Updated
Jul 13 closing price
Net Assets
102.14M
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

EAERX vs VSTSX

EAERX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
EAERX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EAERX is a StrongBuy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. EAERX (102M). VSTSX pays higher dividends than EAERX: VSTSX (1.07) vs EAERX (0.00). EAERX was incepted earlier than VSTSX: EAERX (25 years) vs VSTSX (10 years). EAERX (1.10) is less costly to investors than VSTSX (0.01). EAERX is a more actively managed with annual turnover of: 42.00 vs. VSTSX (3.00). EAERX has a lower initial minimum investment than VSTSX: EAERX (1000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. EAERX (3.75). VSTSX return over 5 years is better than : 66.56 vs. EAERX (-8.74).
EAERXVSTSXEAERX / VSTSX
Total Expense Ratio0.980.019,800%
Annual Report Gross Expense Ratio1.100.0111,000%
Fund Existence25 years10 years-
Gain YTD6.21611.20555%
Front Load5%N/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets102M2.3T0%
Annual Yield % from dividends0.001.07-
Returns for 1 year3.7521.4817%
Returns for 3 years15.5167.0623%
Returns for 5 years-8.7466.56-13%
Returns for 10 years50.43239.5321%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I